Immune checkpoint inhibition (ICI) in current systemic therapies for hepatocellular carcinoma (HCC)
Immune checkpoint inhibition (ICI) has revolutionized cancer therapy, including treatment of hepatocellular carcinoma (HCC) which comprises 80%-90% of all liver cancers, the third most common cause of cancer-related death worldwide. The main targeted pathways are the cytotoxic T-lymphocyte-associate...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2023-10-01
|
| Serier: | ESMO Gastrointestinal Oncology |
| Fag: | |
| Online adgang: | http://www.sciencedirect.com/science/article/pii/S2949819823000055 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
